Trial intelligence / Profile preview

Pharmacoscintigraphy of Novel Delayed-release Diclofenac vs Voltaren

NCT02714842Phase 1Completed

Sponsor
BDD Pharma
Start
Mar 2016
Primary completion
May 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of diclofenac in pain (4 arms), sponsored by BDD Pharma. Primary endpoints: Gastric Emptying Time at 16 hours, Small Intestinal Transit Time at 16 hours and 1 more. Started Mar 2016; status: completed.

02

Drugs

diclofenac
03

Conditions

pain

Beyond the preview

Go deeper on NCT02714842.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02714842.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call